949 results on '"Rothstein, Jeffrey D"'
Search Results
202. Efficacy of local polymer-based and systemic delivery of the anti-glutamatergic agents riluzole and memantine in rat glioma models
203. The Role of NG2 Glial Cells in ALS Pathogenesis
204. Identification of a unique TGF-β–dependent molecular and functional signature in microglia
205. Oligodendroglia: metabolic supporters of axons
206. RNA Toxicity from the ALS/FTD C9ORF72 Expansion Is Mitigated by Antisense Intervention
207. Increased expression of glutamate transporter GLT-1 in peritumoral tissue associated with prolonged survival and decreases in tumor growth in a rat model of experimental malignant glioma
208. Human Stem Cell-Derived Spinal Cord Astrocytes with Defined Mature or Reactive Phenotypes
209. Degeneration and impaired regeneration of gray matter oligodendrocytes in amyotrophic lateral sclerosis
210. The blood-brain barrier: an engineering perspective
211. The transcription factor Pax6 contributes to the induction of GLT-1 expression in astrocytes through an interaction with a distal enhancer element.
212. Generation of GFAP::GFP Astrocyte Reporter Lines from Human Adult Fibroblast-Derived iPS Cells Using Zinc-Finger Nuclease Technology.
213. Multimodal Actions of Neural Stem Cells in a Mouse Model of ALS: A Meta-Analysis
214. Deletion of galectin‐3 exacerbates microglial activation and accelerates disease progression and demise in a SOD1 G93A mouse model of amyotrophic lateral sclerosis
215. Oligodendroglia metabolically support axons and contribute to neurodegeneration
216. Derivation of Glial Restricted Precursors from E13 mice
217. Localization of a toxic form of superoxide dismutase 1 protein to pathologically affected tissues in familial ALS
218. Human nasal olfactory epithelium as a dynamic marker for CNS therapy development
219. Neuronal activity regulates glutamate transporter dynamics in developing astrocytes
220. Plasticity of astroglial networks in olfactory glomeruli
221. A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD
222. Harmine, a natural beta-carboline alkaloid, upregulates astroglial glutamate transporter expression
223. John W. “Jack” Griffin, MD
224. Spatial and temporal changes in promoter activity of the astrocyte glutamate transporter GLT1 following traumatic spinal cord injury
225. New Treatments in Amyotrophic Lateral Sclerosis
226. Molecular comparison of GLT1+ and ALDH1L1+ astrocytes in vivo in astroglial reporter mice
227. NG2+ CNS Glial Progenitors Remain Committed to the Oligodendrocyte Lineage in Postnatal Life and following Neurodegeneration
228. Zones of Enhanced Glutamate Release from Climbing Fibers in the Mammalian Cerebellum
229. Quantitative analysis of EAAT4 promoter activity in neurons and astrocytes of mouse somatic sensory cortex
230. Anti-Excitotoxic and Antioxidant TGF-Beta Family Neurotrophic Factors: In Vitro Screening Models of Motor Neuron Degeneration
231. A phase II trial of talampanel in subjects with amyotrophic lateral sclerosis
232. Tumor necrosis factor-α modulates glutamate transport in the CNS and is a critical determinant of outcome from viral encephalomyelitis
233. Presynaptic Regulation of Astroglial Excitatory Neurotransmitter Transporter GLT1
234. Epigenetic regulation of neuron-dependent induction of astroglial synaptic protein GLT1
235. Current hypotheses for the underlying biology of amyotrophic lateral sclerosis
236. Anti-Excitotoxic and Antioxidant TGF-BETA Family Neurotrophic Factors: In Vitro Screening Models of Motor Neuron Degeneration
237. Focal transplantation–based astrocyte replacement is neuroprotective in a model of motor neuron disease
238. Messenger RNA Oxidation Occurs Early in Disease Pathogenesis and Promotes Motor Neuron Degeneration in ALS
239. The Endoplasmic Reticulum Exit of Glutamate Transporter Is Regulated by the Inducible Mammalian Yip6b/GTRAP3-18 Protein
240. Reticulon RTN2B Regulates Trafficking and Function of Neuronal Glutamate Transporter EAAC1
241. Intraparenchymal spinal cord delivery of adeno-associated virus IGF-1 is protective in the SOD1G93A model of ALS
242. ALS - Motor Neuron Disease: Mechanism and Development of New Therapies
243. TDP‐43 in amyotrophic lateral sclerosis: Pathophysiology or patho‐babel?
244. Therapeutic immunization with a glatiramer acetate derivative does not alter survival in G93A and G37R SOD1 mouse models of familial ALS
245. Targeting an Old Mechanism in a New Disease—Protection of Glutamatergic Dysfunction in Depression
246. Analysis of cerebellar Purkinje cells using EAAT4 glutamate transporter promoter reporter in mice generated via bacterial artificial chromosome-mediated transgenesis
247. Analysis of IFT74as a candidate gene for chromosome 9p-linked ALS-FTD
248. Regulation of Neurotransmitter Aspartate Metabolism by Glial Glutamine Synthetase
249. The Glutamate–Aspartate Transporter GLAST Mediates Glutamate Uptake at Inner Hair Cell Afferent Synapses in the Mammalian Cochlea
250. Recovery from paralysis in adult rats using embryonic stem cells
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.